flufenamic acid has been researched along with tafamidis in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Choi, S; Connelly, S; Johnson, SM; Kelly, JW; Mortenson, DE; Powers, ET; Wilson, IA | 1 |
| Mizuguchi, M; Yokoyama, T | 1 |
| Arsequell, G; Blasi, D; Busquets, MA; Cardoso, I; Cotrina, EY; Gales, L; Gimeno, A; Jiménez-Barbero, J; Leite, JP; Liz, MA; Llop, J; Planas, A; Prohens, R; Quintana, J; Rivas, J; Santos, LM | 1 |
1 review(s) available for flufenamic acid and tafamidis
| Article | Year |
|---|---|
Transthyretin Amyloidogenesis Inhibitors: From Discovery to Current Developments.
Topics: Amyloid; Crystallography, X-Ray; Drug Discovery; Humans; Molecular Structure; Prealbumin | 2020 |
2 other study(ies) available for flufenamic acid and tafamidis
| Article | Year |
|---|---|
Semi-quantitative models for identifying potent and selective transthyretin amyloidogenesis inhibitors.
Topics: Amyloid Neuropathies, Familial; Computer Simulation; Drug Design; Humans; Molecular Docking Simulation; Prealbumin; Protein Multimerization; Protein Stability; Small Molecule Libraries | 2017 |
Targeting transthyretin in Alzheimer's disease: Drug discovery of small-molecule chaperones as disease-modifying drug candidates for Alzheimer's disease.
Topics: Alzheimer Disease; Calorimetry; Dose-Response Relationship, Drug; Drug Discovery; Humans; Models, Molecular; Molecular Chaperones; Molecular Structure; Prealbumin; Small Molecule Libraries; Software; Structure-Activity Relationship | 2021 |